‘Huang Qi Elixir’ for proteinuria in patients with diabetic nephropathy: a study protocol for a randomized controlled pilot trial

BACKGROUND: Diabetic nephropathy (DN) is the major complication of diabetes; proteinuria is the hall mark of DN. Currently, the treatment for proteinuria is mainly limited to angiotensin converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs). According to Traditional Chinese M...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Xiang, Liu, Fang, Jordan, James B, Ye, Xue Feng, Fu, Ping, Wang, Fei, Zhong, Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725160/
https://www.ncbi.nlm.nih.gov/pubmed/23866835
http://dx.doi.org/10.1186/1745-6215-14-223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725160/
https://www.ncbi.nlm.nih.gov/pubmed/23866835
http://dx.doi.org/10.1186/1745-6215-14-223

Ejemplares similares